相似文献
1
Methanocarba ring as a ribose modification in ligands of G protein-coupled purine and pyrimidine receptors: synthetic approaches.
Medchemcomm. 2013 Dec 17;2013(4):619-630. doi: 10.1039/C2MD20348K.
2
Pyrimidine Nucleotides Containing a (S)-Methanocarba Ring as P2Y Receptor Agonists.
Medchemcomm. 2017 Oct 1;8(10):1897-1908. doi: 10.1039/C7MD00397H. Epub 2017 Sep 6.
3
Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
J Med Chem. 2002 May 9;45(10):2090-100. doi: 10.1021/jm010538v.
4
2-Substitution of adenine nucleotide analogues containing a bicyclo[3.1.0]hexane ring system locked in a northern conformation: enhanced potency as P2Y1 receptor antagonists.
J Med Chem. 2003 Nov 6;46(23):4974-87. doi: 10.1021/jm030127+.
5
Methanocarba modification of uracil and adenine nucleotides: high potency of Northern ring conformation at P2Y1, P2Y2, P2Y4, and P2Y11 but not P2Y6 receptors.
J Med Chem. 2002 Jan 3;45(1):208-18. doi: 10.1021/jm010369e.
6
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists.
J Med Chem. 2000 Jun 1;43(11):2196-203. doi: 10.1021/jm9905965.
7
Synthesis of ethyl (1S,2R,3S,4S,5S)-2,3-O-(isopropylidene)-4-hydroxy-bicyclo[3.1.0]hexane-carboxylate from L-ribose: a versatile chiral synthon for preparation of adenosine and P2 receptor ligands.
Nucleosides Nucleotides Nucleic Acids. 2008 Mar;27(3):279-91. doi: 10.1080/15257770701845253.
8
Nucleotide analogues containing 2-oxa-bicyclo[2.2.1]heptane and l-alpha-threofuranosyl ring systems: interactions with P2Y receptors.
Bioorg Med Chem. 2004 Nov 1;12(21):5619-30. doi: 10.1016/j.bmc.2004.07.067.
9
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands.
J Med Chem. 2000 Mar 9;43(5):829-42. doi: 10.1021/jm990249v.
10
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
J Med Chem. 2010 Jun 10;53(11):4488-501. doi: 10.1021/jm100287t.
引用本文的文献
1
Survey of ribose ring pucker of signaling nucleosides and nucleotides.
Nucleosides Nucleotides Nucleic Acids. 2020;39(1-3):322-341. doi: 10.1080/15257770.2019.1658115. Epub 2019 Aug 28.
2
Polypharmacology of conformationally locked methanocarba nucleosides.
Drug Discov Today. 2017 Dec;22(12):1782-1791. doi: 10.1016/j.drudis.2017.07.013. Epub 2017 Aug 3.
3
Structure-Based Design, Synthesis by Click Chemistry and Activity of Highly Selective A Adenosine Receptor Agonists.
Medchemcomm. 2015;6:555-563. doi: 10.1039/C4MD00571F.
4
John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.
Comput Struct Biotechnol J. 2014 Oct 16;13:286-98. doi: 10.1016/j.csbj.2014.10.004. eCollection 2015.
5
In vivo phenotypic screening for treating chronic neuropathic pain: modification of C2-arylethynyl group of conformationally constrained A3 adenosine receptor agonists.
J Med Chem. 2014 Dec 11;57(23):9901-14. doi: 10.1021/jm501021n. Epub 2014 Nov 25.
本文引用的文献
1
Truncated Nucleosides as A(3) Adenosine Receptor Ligands: Combined 2-Arylethynyl and Bicyclohexane Substitutions.
ACS Med Chem Lett. 2012 Jul 12;3(7):596-601. doi: 10.1021/ml300107e. Epub 2012 Jun 11.
2
Structural sweet spot for A1 adenosine receptor activation by truncated (N)-methanocarba nucleosides: receptor docking and potent anticonvulsant activity.
J Med Chem. 2012 Sep 27;55(18):8075-90. doi: 10.1021/jm300965a. Epub 2012 Sep 10.
3
Structure-guided design of A(3) adenosine receptor-selective nucleosides: combination of 2-arylethynyl and bicyclo[3.1.0]hexane substitutions.
J Med Chem. 2012 May 24;55(10):4847-60. doi: 10.1021/jm300396n. Epub 2012 May 16.
4
Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.
J Med Chem. 2012 Jun 28;55(12):5676-703. doi: 10.1021/jm300087j. Epub 2012 Apr 17.
5
Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition Element.
ACS Med Chem Lett. 2011 Aug 11;2(8):626-631. doi: 10.1021/ml200114q.
6
Molecular pharmacology, physiology, and structure of the P2Y receptors.
Adv Pharmacol. 2011;61:373-415. doi: 10.1016/B978-0-12-385526-8.00012-6.
7
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.
Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8.
8
Recent developments in adenosine receptor ligands and their potential as novel drugs.
Biochim Biophys Acta. 2011 May;1808(5):1290-308. doi: 10.1016/j.bbamem.2010.12.017. Epub 2010 Dec 23.
9
Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
J Med Chem. 2010 Jun 10;53(11):4488-501. doi: 10.1021/jm100287t.
10
2-Dialkynyl derivatives of (N)-methanocarba nucleosides: 'Clickable' A(3) adenosine receptor-selective agonists.
Bioorg Med Chem. 2010 Jan 15;18(2):508-17. doi: 10.1016/j.bmc.2009.12.018. Epub 2009 Dec 11.
Zotero 插件